Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: In vitro and in vivo studies

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 2358-2367

  Delgado, Mario ^a,c   Pozo, David ^b   Martinez, Carmen ^a   Leceta, Javier ^a   Calvo, Juan Ramon ^b   Ganea, Doina ^c   Gomariz, Rosa P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c Rutgers University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE INFECTION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; NORTHERN BLOTTING; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

EID: 0033558092     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.162.4.2358     Document Type: Article

References (51)

1. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell. Biol. 9:317.
2. De la Fuente, M., M. Delgado, and R. P. Gomariz. 1996. VIP modulation of immune cell functions. Adv. Neuroimmunol. 6:75.
3. Segura, J. J., J. M. Guerrero, R. Goberna, and J. R. Calvo. 1991. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Regul. Pept. 33:133.
4. Delgado, M., D. Pozo, C. Martinez, E. Garrido, J. Leceta, J. R. Calvo, and R. P. Gomariz. 1996. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages Regul. Pept. 62:161.
5. Pozo, D., M. Delgado, C. Martinez, R. P. Gomariz, J. M. Guerrero, and J. R. Calvo. 1997. Functional characterization and mRNA expression of pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages. Biochim. Biophys. Acta 1359:250.
6. Ganea, D. 1996. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol. 6:61.
7. Martinez, C., M. Delgado, D. Pozo, J. Leceta, J. R. Calvo, D. Ganea, and R. P. Gomariz. 1998. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. J. Leukocyte Biol. 63:591.
8. Platzer, C., C. Meisel, K. Vogt, M. Platzer, and H. D. Volk. 1995. Upregulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7:517.
9. Engelberts, I., A. Moller, G. J. M. Schoen, C. J. Van der Linden, and W. A. Buurman. 1991. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res. 10:69.
10. Fransen, L., R. Mueller, A. Marmenout, J. Tavernier, J. Van der Heyden, E. Kawashima, A. Collet, R. Tizard, H. Van Heuverswyn, A. Van Vliet, et al. 1985. Molecular cloning of mouse tumor necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res. 13:4417.
11. Gomariz, R. P., E. Garrido, J. Leceta, C. Martinez, R. Abalo, and M. Delgado. 1994. Gene expression of VIP receptor in rat lymphocytes. Biochem. Biophys. Res. Commun. 203:1599.
12. Tatsuno, I., P. E. Gottschall, and A. Arimura. 1991. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase-activating polypeptide: a comparative study with vasoactive intestinal peptide. Endocrinology 128:728.
13. Xin, Z., H. Tang, and D. Ganea. 1994. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via TCR/CD3 complex. J. Neuroimmunol. 54:59.
14. Martinez, C., M. Delgado, R. P. Gomariz, and D. Ganea. 1996. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes. J. Immunol. 156:4128.
15. Gourlet, P., M. C. Vandermeers-Piret, J. Rathe, P. De Neef, and P. Robberecht. 1995. Fragments of pituitary adenylate cyclase-activating polypeptide discriminate between type I and II recombinant receptors. Eur. J. Pharmacol. 287:7.
16. 2 as a VIP antagonist. Endocrinology 116:2643.
17. 1 receptor. Peptides 18:1555.
18. 1 receptor agonists. Peptides 18:1539.
19. Kobayashi, E., H. Nakno, M. Morimoto, and T. Tamaoki. 1989. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548.
20. Boige, N., B. Aminaroff, A. Munk, and M. Laburthe. 1984. Forskolin stimulates adenylale cyclase in human colonic crypts: interaction with VIP. Eur. J. Pharmacol. 101:111.
21. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced neunte outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromociannamylamino)ethyl]-5-isoquinoleinsulfonamide (H89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267.
22. Uchida, D., A. Arimura, A. Somogyvri-Vigh, S. Shioda, and W. A. Banks. 1996. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res. 736:280.
23. Saidm S. I. 1985. Vasoactive intestinal peptide. In Airways Smooth Muscle: Peptide Receptors. Ion Channels and Signal Transduction. D. Raeburn and M. A. Giembycz, eds. Birkhauser Verlag, Basel, p. 87.
24. Foda, H. D., T. Iwanaga, L. W. Liu, and S. I. Said. 1988. Vasoactive intestinal peptide protects against HCI-induced pulmonary edema in rats. Ann. NY Acad. Sci. 527:633.
25. Berisha, H., H. D. Foda, H. Sakakibara, D. Trotz, H. Pakbaz, and S. I. Said. 1990. Vasoactive intestinal peptide prevents lung injury due to xanthine/xanthine oxidase. Am. J. Physiol. 259:L151.
26. Kurosawa, M., and T. Ishizuka. 1993. Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by N-formyl-methionyl-leucyl-phenylalanine-activated inflammatory cells in vitro. Int. Arch. Allergy Appl. Immunol. 100:28.
27. Pozo, D., J. R. Calvo, and J. M. Guerrero. 1995. Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages. Peptides 16:313.
28. Gourlet, P., J.-P. Vilardaga, P. DeNeef, M. Waelbroeck, A. Vandermeers, and P. Robberecht. 1996. The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides 17:825.
29. O'Donnell, M., R. J. Garippa, N. C. O'Neill, D. R. Bolin, and J. M. Cottrell. 1991. Structure-activity studies of vasoactive intestinal polypeptide. J. Biol. Chem. 266:6389.
30. Calvo, J. R., D. Pozo, and J. M. Guerrero. 1996. Functional and molecular characterization of VIP receptors and signal transduction in human and rodent immune systems. Adv. Neuroimmunol. 6:39.
31. Calvo, J. R., M. L. Montilla, J. M. Guerrero, and J. J. Segura. 1994. Expression of VIP receptors in mouse peritoneal macrophages: functional and molecular characterization. J. Neuroimmunol. 50:85.
32. Pozo, D., J. J. Segura, I. Carrero, L. G. Guijarro, J. C. Prieto, and J. R. Calvo. 1996. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophages membranes. Biochim. Biophys. Acta 1312:249.
33. Kovacs, E. J., D. Radzioch, H. A. Young, and L. Varesio. 1988. Differential inhibition of IL-1 and TNF-α mRNA expression by agents which block second messenger pathways in murine macrophages. J. Immunol. 141:3101.
34. Severn, A., N. T. Rapson, C. A. Hunter, and F. Y. Liew. 1992. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J. Immunol. 148:3441.
35. 2 and cyclic nucleotides. J. Immunol. 141:2388.
36. Bouma, M. G., R. K. Stad, F. A. J. M. Van den Wildenberg, and W. A. Buurman. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:4159.
37. Delgado, M., E. J. Munoz-Elias, Y. Kan, I. Gozes, M. Fridkin, D. E. Brenneman, R. P. Gomariz, and D. Ganea. 1999. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit TNFα transcriptional activation by regulating NF-κB and CREB/c-Jun. J. Biol. Chem. 273:31427.
38. Gaytan, F., A. J. Martinez-Fuentes, F. Gracia-Navarro, H. Vaudry, and E. Aguilar. 1994. Pituitary adenylale cyclase-activating polypeptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell Tissue Res. 276:223.
39. Baumann, H., A. J. Symes, M. R. Comeau, K. K. Morella, Y. Wang, D. Friend, S. F. Ziegler, J. S. Fink, and D. P. Gearing. 1994. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol. Cell. Biol. 14:138.
40. Ferguson, T. A., S. Fletcher, J. Herndon, and T. S. Griffith. 1995. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J. Immunol. 155:1746.
41. Rao, M. S., Y. Sun, U. Vaidyanathan, S. C. Landis, and R. E. Zigmond. 1993. Regulation of substance P is similar to that vasoactive intestinal peptide after axotomy or explantation of the rat superior cervical ganglion. J. Neurobiol. 24: 571.
42. Eskay, R. L., and L. E. Eiden. 1992. Interleukin-1α and tumor necrosis factor-α differentially regulate enkephalin, vasoactive intestinal peptide, neurotensin, and substance P biosynthesis in chromaffin cells. Endocrinology 130:2252.
43. Kaltreider, H. B., S. Ichikawa, P. K. Byrd, D. A. Ingram, J. L. Kishiyama, S. P. Sreedharan, M. L. Warnock, J. M. Beck, and E. J. Goetzl. 1997. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am. J. Respir. Cell Mol. Biol. 16:133.
44. Segura, J. J., J. M. Guerrero, D. Pozo, J. R. Calvo. 1996. Expression of vasoactive intestinal peptide binding sites in rat peritoneal macrophages is stimulated by inflammatory stimulus. J. Neuroimmunol. 64:1.
45. Brandtzaeg, P., O. Oktedalen, P. Kierulf, and P. K. Opstad. 1989. Elevated VIP and endotoxin plasma levels in human Gram-negative septic shock. Regul. Pept. 24:37.
46. Higashiguchi, T., Y. Noguchi, A. Noffsinger, J. E. Fischer, P. O. Hasselgren. 1994. Sepsis increases production of total secreted proteins, vasoactive intestinal peptide, and peptide YY in isolated rat enterocytes. Am. J. Surg. 168:251.
47. Zamir, O., P. O. Hasselgren, T. Higashiguchi, J. A. Frederick, and J. E. Fischer. 1992. Effect of sepsis or cytokine administration on release of gut peptides. Am. J. Surg. 163:181.
48. Revhaug, A., I. Lygren, T. I. Lundgren, O. K. Andersen, P. G. Burhol, and K. E. Giercksky. 1985. Increased plasma levels of vasoactive intestinal peptide in pigs during endotoxemia. Eur. Surg. Res. 17:75.
49. Broner, C. W., M. S. O'Dorisio, R. B. Rosenberg, and T. M. O'Dorisio. 1995. Cyclic nucleotides and vasoactive intestinal peptide production in a rabbit model of Escherichia coli septicemia. Am. J. Med. Sci. 309:267.
50. Delgado, M., C. Martinez, D. Pozo, J. R. Calvo, J. Leceta, D. Ganea, and R. P. Gomariz. 1999. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6. J. Immunol. 162, In press.
51. Suzuki, Y., K. Kasai, I. Lino, K. Takekoshi, M. Oka, and S. Shimoda. 1994. Anti-shock effect of pituitary adenylate cyclase activating polypeptide (PACAP) on experimental endotoxin shock in dogs. Life Sci. 54:389.